| Literature DB >> 28484678 |
Alexa M Dessy1, Frank J Yuk1, Akbar Y Maniya1, James G Connolly2, John T Nathanson1, Jonathan J Rasouli1, Tanvir F Choudhri1.
Abstract
BACKGROUND: Postoperative surgical site infection (SSI) is a common complication after spine surgery. Reduction of SSI has many benefits including, but not limited to, the reduced length of stay, readmission rates, and morbidity and mortality.Entities:
Keywords: antibiotic prophylaxis; infection; spine surgery; surgical site infection
Year: 2017 PMID: 28484678 PMCID: PMC5419816 DOI: 10.7759/cureus.1139
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Standard and enhanced prophylaxis protocol measures
Comparison of the standard protocol versus enhanced protocol. Dosage and administration of antibiotics were calculated based on patient’s weight and renal clearance. Standard doses were not used.
1. Two isopropyl alcohol wipes swabbed over incision site and immediate surrounding regions six times. 2. Betadine ointment applied to incision site and immediate surrounding region after use of alcohol wipes. Only used in skin preparation, not after closure. 3. Drains were removed when output reached < 30 cc/eight hour shift. 4. Drains used regularly for instrumented cases and selectively for non-instrumented cases.
| Indication | Standard Protocol | Enhanced Protocol |
| Patient Skin Preparation | Standard betadine/iodine scrub/paint. Select use of alcohol pads |
Three betadine scrub brushes Six alcohol wipes on incision area1 Betadine ointment application2 |
| Alcohol Pad Preparation | Select use | Regular use |
| Patient Prep Performance | Select attending performance | Regular attending performance |
| Pulse Irrigator (Saline with Bacitracin) | Select use | Regular use for posterior instrumentation |
| Surgical Drains3 | Select use | Regular use4 |
| Prophylactic Antibiotic Coverage (unless allergic) | IV Cefuroxime for 24 hours Select use of IV Vancomycin (in case of cephalosporin allergy only) |
Regular use for the posterior instrumentation:
IV Cefuroxime for 24 hoursIV Vancomycin until drain removal |
Centers for Disease Control and Prevention (CDC) Surgical site infection (SSI) definitions
Definition of superficial and deep incisional SSI criteria based on Centers for Disease Control and Prevention [20].
| Indication | Superficial Incisional SSI Criteria | Deep Incisional SSI Criteria |
| Timeline | MUST occur within 30 days after operative procedure |
MUST occur within:
30 days of operative procedure if NO implant left in place One year if implant left in place |
| Tissue Involvement | MUST involve only skin and subcutaneous tissue of the incision | MUST involve deep soft tissues (fascial and muscle layers) of the incision |
| Drainage, Culture, Symptoms |
At least one of the following:
Purulent drainage from incision Organisms isolated from aseptically obtained culture At least one of the following signs or symptoms of infection and the superficial incision Pain Redness Tenderness Localized swelling Heat |
At least one of the following:
Purulent drainage from the deep incision but not the organ space component Deep incision spontaneously dehisces or is deliberately opened by the surgeon and is culture positive OR not cultured when the patient has at least one of the following: Fever Localized pain Tenderness |
| Diagnosis | By surgeon or attending physician | By surgeon or attending physician |
Patient demographics
Patient demographics of both cohorts demonstrating similar mean age, percent of male patients, mean body mass index, mean American Society of Anesthesiologist physical status classification and length of surgery.
| Standard Protocol (n=394) | Enhanced Protocol (n=1092) | |
| Mean Age (years) | 51.2 ± 16.2 | 56.9 ± 14.4 |
| % Male | 57.9 | 50.6 |
| Mean BMI | 26.88 ± 5.11 | 27.65 ± 5.61 |
| Mean ASA Status | 2.42 ± 0.74 | 2.54 ± 0.68 |
| Surgery Length (hours) | 4.17 ± 2.02 | 4.23 ± 1.86 |
Incidence of surgical site infections by operative region of the spine
Incidence of surgical site infections by operative region of the spine shows that the majority of cases were cervical site infections. After the institution of the enhanced protocol, no further surgical site infections were observed.
| Standard Protocol | Enhanced Protocol | Total | ||||
| Operative Region | Cases (% Total) | Infections (%) | Cases (% Total) | Infections (%) | Cases (% Total) | Infections (%) |
| Cervical | 164 (41.6) | 4 (2.44) | 532 (48.7) | 0 | 696 (46.8) | 4 (0.57) |
| Thoracic | 57 (14.5) | 2 (3.51) | 90 (8.3) | 0 | 147 (9.9) | 2 (1.36) |
| Lumbar | 173 (43.9) | 3 (1.73) | 470 (43.0) | 0 | 643 (43.4) | 3 (0.47) |
| Total | 394 (100) | 9 (2.28) | 1092 (100) | 0 | 1486 (100) | 9 (0.61) |
Incidence of surgical site infections by operative region on a posterior approach
All cases of surgical site infections were observed using a posterior operative approach. No further cases of SSI were observed after the institution of the enhanced protocol (p < 0.0001) across all regions of the spine. However, statistical significance was reached only for cervical and lumbar cases (p < 0.0042 and p < 0.0119, respectively).
| Standard Protocol | Enhanced Protocol | Total | |||||
| Operative Region | Cases (% Total) | Infections (%) | Cases (% Total) | Infections (%) | Cases (% Total) | Infections (%) | P-value |
| Cervical | 71 (29.7) | 4 (5.63) | 203 (29.6) | 0 | 274 (29.7) | 4 (1.46) | 0.0042 |
| Thoracic | 45 (18.8) | 2 (4.44) | 70 (10.2) | 0 | 115 (12.4) | 2 (1.74) | 0.1510 |
| Lumbar | 123 (51.5) | 3 (2.44) | 412 (60.2) | 0 | 535 (57.9) | 3 (0.56) | 0.0119 |
| Total | 239 (100) | 9 (3.77) | 685 (100) | 0 | 924 (100) | 9 (0.97) | < 0.0001 |
Surgical wound culture microbiology
Six of the nine surgical site infections contained methicillin-resistant Staphylococcus aureus.
| Case | Operative Region | Organisms Detected |
| 1 | Cervical |
Methicillin-resistant |
| 2 | Cervical |
Methicillin-susceptible |
| 3 | Cervical |
Coagulase-negative |
| 4 | Cervical |
Coagulase-negative |
| 5 | Thoracic |
Methicillin-resistant |
| 6 | Thoracic |
Methicillin-resistant |
| 7 | Lumbar |
Methicillin-resistant |
| 8 | Lumbar |
Methicillin-resistant |
| 9 | Lumbar |
Methicillin-resistant |